Apalutamide/ADT Demonstrate s 100% Biochemical RFS Rate in High-Risk Prostate Cancer

Apalutamide and ADT elicited a 100% biochemical recurrence-free survival rate at 24 months in high-risk localized prostate cancer following radical prostatectomy.

Related Keywords

San Antonio ,Texas ,United States ,Oakland University ,Michigan ,American ,Jason Hafron ,Michigan Institute Of Urology ,American Urological Association Meeting ,American Urological Association Annual Meeting ,William Beaumont School Of Medicine ,Urological Association Annual ,Michigan Institute ,William Beaumont School ,Urological Association Meeting ,